申请人:ABBVIE B.V.A
公开号:US20140080861A1
公开(公告)日:2014-03-20
The present invention relates to heterocyclic compounds of formula (I) having affinity to mascarinic receptors, a pharmaceutical composition containing the compounds, as well as the use of the compounds for the preparation of a medicament for treating, alleviating or prevention muscarinic receptor medicated diseases and conditions.
本发明涉及具有亲和力的式(I)杂环化合物,用于治疗、缓解或预防胆碱能受体介导的疾病和病况的药物组合物,以及用于制备药物的化合物的使用。